Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Regulus Receives FDA Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome

July 21, 2014 8:07 am | News | Comments

Regulus Therapeutics Inc., announced today that the FDA has granted orphan drug designation to RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21, as a therapeutic for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.

TOPICS:

Results From Phase 3 VIVID-DME Trial of EYLEA Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement

July 18, 2014 9:31 am | News | Comments

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that in the Phase 3 VIVID-DME trial of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser photocoagulation.

TOPICS:

AIDS Researchers Killed In Malaysian Plane Crash

July 18, 2014 9:22 am | by KRISTEN GELINEAU, Associated Press | News | Comments

A large number of world-renowned AIDS researchers and activists heading to an international AIDS conference in Australia were on board a Malaysian jetliner that was shot down over Ukraine, officials said Friday, as news of their deaths sparked an outpouring of grief across the global scientific community.

Advertisement

AbbVie & Shire Agree On $55B Combination

July 18, 2014 9:16 am | by TOM MURPHY, AP Business Writer | News | Comments

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire.                                        

TOPICS:

AstraZeneca Reveals Designs For New R&D Center & Corporate HQ In Cambridge, UK

July 18, 2014 9:08 am | by AstraZeneca | News | Comments

AstraZeneca today revealed the proposed designs for its new Global R&D Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D Enabling Building and an Energy Centre.

TOPICS:

Newly Discovered Gene Stops The Spread Of Cancer

July 17, 2014 4:10 pm | by Salk Institute | News | Comments

Scientists at the Salk Institute have identified a gene responsible for stopping the movement of cancer from the lungs to other parts of the body, indicating a new way to fight one of the world's deadliest cancers.                             

TOPICS:

Researcher Unlocks Next Step in Creating HIV-1 Immunotherapy

July 17, 2014 4:06 pm | by George Washington University School of Medicine & Health Sciences | News | Comments

The road to finding a cure for HIV-1 is not without obstacles. However, thanks to cutting-edge research performed at the George Washington University (GW), Oregon Health & Science University, the University of Rochester, and UC San Francisco, the scientific community is one step closer to finding a viable immunotherapy option for HIV-1, using an immune attack against a fossil virus buried in the genome.

TOPICS:

Borosilicate Glass Culture Tubes

July 17, 2014 3:44 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

These new glass culture tubes are made from quality borosilicate glass to reduce pH changes and contaminants that can be leached from soda lime glass tubes. 

Advertisement

Portable Purge & Trap GC System

July 17, 2014 3:28 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

Introducing the Frog-4000, a fully contained purge and trap GC system with analytical capabilities that are comparable to a commercial lab with the advantage of its compact size. 

GTCR to Acquire Cole-Parmer Instrument Company

July 17, 2014 1:55 pm | News | Comments

GTCR, a private equity firm, has entered into a definitive agreement to acquire the Cole-Parmer Instrument Company from Thermo Fisher Scientific Inc. for $480 million. Cole-Parmer, headquartered in Vernon Hills, Illinois, is a global manufacturer and distributor of specialty laboratory equipment, instruments and supplies to a diverse range of industries.

TOPICS:

FDA Approves New Product to Treat Rare Genetic Disease

July 17, 2014 10:22 am | News | Comments

The FDA has approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).           

TOPICS:

Researchers Target ALS With Stem Cells

July 17, 2014 8:58 am | Videos | Comments

The Mayo Clinic is testing the safety and effectiveness of taking stem cells from a patient's own fat and injecting them into their spinal fluid to slow the progression of ALS.             

TOPICS:

CDC Director Admits Safety Problems at Germ Labs

July 17, 2014 8:44 am | by MIKE STOBBE, AP Medical Writer | News | Comments

The director of the Centers for Disease Control and Prevention acknowledged Wednesday that systemic safety problems have for years plagued federal public health laboratories that handle dangerous germs such as anthrax and bird flu.   

TOPICS:

Trying Gene Therapy to Create a Biological Pacemaker

July 17, 2014 8:33 am | by LAURAN NEERGAARD, AP Medical Writer | News | Comments

No batteries required: Scientists are creating a biological pacemaker by injecting a gene into the hearts of sick pigs that changed ordinary cardiac cells into a special kind that induces a steady heartbeat.       

TOPICS:

300 Vials Labeled Influenza, Dengue Found at Lab

July 17, 2014 8:26 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

FDA officials said Wednesday the undocumented collection contained 327 carefully packaged vials, listing pathogens like dengue, influenza and rickettsia. Last week the government only disclosed that it had recovered six glass vials of smallpox dating from the 1950s.        

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading